Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new revision entry (v3.3.2) and removed the previous revision entry (v3.2.0) from the record history.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding notice banner at the top of the page was removed.SummaryDifference0.6%

- Check49 days agoChange DetectedThe changes appear to be minor UI and layout adjustments with no substantive changes to study details or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

- Check78 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

- Check92 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 and removed the Back to Top navigation element.SummaryDifference0.7%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.